The studies by Guo et al.24 and Han et al.46 both included a group of animals receiving butylphthalide, a non-specific traditional medication) as positive controls, and presented data tentatively indicate that this group experience conferred greater reductions in cerebral infarction volume than those receiving specific HDAC6 inhibitors. The gene discussed is HDAC6; the disease is brain infarction.